MOXD2P

Model summary

A secreted, copper-dependent monooxygenase that assembles a DOMON recognition module with a bilobal catalytic core to hydroxylate catecholamine-like substrates using a copper center and ascorbate. Its modular architecture favors extracellular and vesicle-lumen environments, where it binds partners and substrates, catalyzes monooxygenation, and integrates with secretory granules and lysosome-related compartments. By operating in exosomes and secretory pathways, it likely couples enzymatic modification to vesicle-mediated sorting and turnover processes that intersect with ubiquitin-directed degradation.

Predicted Gene Ontology terms

1. 01

   I begin by dissecting the InterPro architecture and its order along the sequence.

   The N-terminus carries a DOMON module: IPR045266 (Copper-dependent monooxygenases, DOMON domain, residues 36–165) and IPR005018 (DOMON domain, residues 40–156). DOMON folds bind catecholamine-like ligands and often act as extracellular/peripheral recognition and electron-transfer modules for copper-dependent monooxygenases. Immediately downstream, the core monooxygenase scaffold appears as a tandem of cupredoxin-like halves: IPR008977 (PHM/PNGase F domain superfamily, residues 179–331) followed by IPR008977 (PHM/PNGase F domain superfamily, residues 336–483). These two blocks together constitute the bilobal catalytic architecture characteristic of copper type II, ascorbate-dependent monooxygenases. This is reinforced by IPR036939 (Copper type II, ascorbate-dependent monooxygenase, N-terminal domain superfamily, residues 182–335) and IPR014784 (Copper type II, ascorbate-dependent monooxygenase, C-terminal superfamily, residues 346–491), which define the N- and C-terminal halves of the catalytic core. The catalytic heart is further specified by IPR000323 (Copper type II, ascorbate-dependent monooxygenase, N-terminal domain, residues 194–314) and IPR024548 (Copper type II ascorbate-dependent monooxygenase, C-terminal domain, residues 335–482), confirming a two-domain monooxygenase that binds and activates O2 in a copper center using ascorbate as an electron donor. The entire polypeptide is classified by IPR000945 (Dopamine beta-hydroxylase-like family, residues 25–494) and multiple DBH/TBH family signatures—IPR028460 (Tyramine beta-hydroxylase/Dopamine beta-hydroxylase families, residues 31–50, 64–86, 128–146, 209–229, 274–293, 337–354)—which collectively anchor the enzyme’s substrate class and catalytic chemistry.

2. 02

   This ordered architecture dictates molecular function.

   The DOMON domain at the N-terminus positions catecholamine-like substrates and stabilizes extracellular/peripheral interactions, while the bilobal copper-monooxygenase core executes hydroxylation chemistry. Together, these features cause GO:0004497 monooxygenase activity and require GO:0005507 copper ion binding for catalysis. The presence of multiple family signatures and the modular assembly also rationalize GO:0005515 protein binding, reflecting assembly with accessory factors and cargo in secretory pathways.

3. 03

   From this chemistry, I infer the biological processes.

   A copper-dependent monooxygenase that modifies catecholamine-like substrates and operates in secretory vesicles naturally interfaces with vesicle biogenesis and cargo maturation. The enzyme’s lumenal/peripheral activity and its association with vesicle pathways connect to vesicle-mediated sorting and turnover. This provides a mechanistic route into GO:0016567 protein ubiquitination and GO:0006511 ubiquitin-dependent protein catabolic process: vesicle trafficking and lysosomal routing are tightly coupled to ubiquitin tagging, and lumenal/peripheral enzymes often influence or depend on ubiquitin-guided degradation and recycling.

4. 04

   Cellular localization follows directly from the architecture and chemistry.

   The DOMON-bearing, copper-monooxygenase scaffold is optimized for extracellular or lumenal environments, consistent with secretion and vesicle lumina. This supports residence in GO:0070062 extracellular exosome and GO:0034774 secretory granule lumen, and extends to specialized lysosome-related organelles such as GO:0035578 azurophil granule lumen and GO:0043202 lysosomal lumen. The experimentally observed secreted status aligns with this extracellular/lumenal design.

5. 05

   Mechanistically, I hypothesize that the enzyme binds copper in the monooxygenase core, accepts electrons from ascorbate, and hydroxylates catecholamine-like ligands or endogenous small-molecule substrates in vesicle and extracellular milieus.

   The DOMON domain concentrates substrates and mediates transient protein binding that organizes vesicle cargo and trafficking machinery. In this context, likely interaction partners include vesicle biogenesis and sorting modules (e.g., adaptor protein complexes and ESCRT-associated factors), secretory pathway enzymes that handle catecholamine precursors and packaging, and copper-handling proteins that provision the catalytic center. These assemblies would couple enzymatic hydroxylation to vesicle maturation and ubiquitin-guided turnover pathways.